---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249204335.md"
description: "As of the close, Vipshop rose 3.20%, Xunlei rose 2.29%, Beigene rose 1.45%, and Autohome rose 0.69%. Zai Lab fell 6.78%, Quantasing fell 4.54%, Tencent Music fell 4.16%, Yatsen fell 3.90%, and Xinyi Technology fell 2.86%"
datetime: "2025-07-18T20:20:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249204335.md)
  - [en](https://longbridge.com/en/news/249204335.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249204335.md)
generator: "portal-rs"
---

# 

As of the close, Vipshop rose by 3.20%, Xunlei rose by 2.29%, Beigene rose by 1.45%, and Autohome rose by 0.69%.

Zai Lab fell by 6.78%, Quantasing fell by 4.54%, Tencent Music fell by 4.16%, Yatsen fell by 3.90%, and Xinyi Technology fell by 2.86%

### Related Stocks

- [YSG.US](https://longbridge.com/en/quote/YSG.US.md)
- [QSG.US](https://longbridge.com/en/quote/QSG.US.md)
- [XNET.US](https://longbridge.com/en/quote/XNET.US.md)
- [ZLAB.US](https://longbridge.com/en/quote/ZLAB.US.md)
- [09688.HK](https://longbridge.com/en/quote/09688.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)

## Related News & Research

- [How Perfect Diary owner Yatsen plans to give its business a glow-up](https://longbridge.com/en/news/299539634.md)
- [FDA Approves Tablet Form of Zanubrutinib for All Approved Indications](https://longbridge.com/en/news/298434766.md)
- [Yatsen Skincare-Led Growth Fails to Prevent Wider Q2 Loss](https://longbridge.com/en/news/297780523.md)
- [Yatsen Group Releases 2025 ESG Report: The Vision of a World-Class Beauty Innovation Pioneer Through Long-Term Value | YSG Stock News](https://longbridge.com/en/news/297921903.md)
- [CLSA: China Biotech Fundamentals Remain Solid; Top Picks BEONE MEDICINES , INNOVENT BIO  and LEADS BIOLABS-B](https://longbridge.com/en/news/297994035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**